Induced pluripotent stem cells in medicine and biology
Open Access
- 15 June 2013
- journal article
- Published by The Company of Biologists in Development
- Vol. 140 (12), 2457-2461
- https://doi.org/10.1242/dev.092551
Abstract
Differentiated cells can be reprogrammed to pluripotency and other cell fates by treatment with defined factors. The discovery of induced pluripotent stem cells (iPSCs) has opened up unprecedented opportunities in the pharmaceutical industry, in the clinic and in laboratories. In particular, the medical applications of human iPSCs in disease modeling and stem cell therapy have been progressing rapidly. The ability to induce cell fate conversion is attractive not only for these applications, but also for basic research fields, such as development, cancer, epigenetics and aging.Keywords
This publication has 53 references indexed in Scilit:
- Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cellsNature, 2013
- Induced pluripotent stem cells: the new patient?Nature Reviews Molecular Cell Biology, 2012
- Mediators of induced pluripotency and their role in cancer cells - current scientific knowledge and future perspectivesBiotechnology Journal, 2012
- Direct generation of functional dopaminergic neurons from mouse and human fibroblastsNature, 2011
- Chemically defined conditions for human iPSC derivation and cultureNature Methods, 2011
- A Murine ESC-like State Facilitates Transgenesis and Homologous Recombination in Human Pluripotent Stem CellsCell Stem Cell, 2010
- Derivation of pluripotent epiblast stem cells from mammalian embryosNature, 2007
- Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem CellsCell, 2003
- A double-blind, placebo-controlled randomized clinical trial of α-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis, 2001
- Expression of a single transfected cDNA converts fibroblasts to myoblastsCell, 1987